Asuragen, Inc.
134 articles about Asuragen, Inc.
-
Xenomics Inc. Announces License with Asuragen, Inc. for NPM1 Leukemia Diagnostics
10/29/2007
-
Asuragen, Inc. Enters Oncology Collaboration with Merck & Co., Inc. to Develop Pharmacogenomic Tests
10/23/2007
-
Asuragen, Inc. Licenses Roche Molecular Systems, Inc.'s Real-time Quantitative PCR Technology for Clinical Gene Expression Profiling
10/8/2007
-
Asuragen, Inc. Launches Powerful New microRNA Analysis Tool
8/2/2007
-
Asuragen, Inc. to Provide GLP Laboratory Testing Services to Aid a Leading Biotechnology Organization
5/29/2007
-
Asuragen, Inc. Becomes The First Certified Service Provider For Illumina Gene Expression Profiling
2/14/2007
-
Asuragen, Inc. Enters Into Licensing Agreement With Yale University For Therapeutic Use Of let-7 miRNA
1/10/2007
-
Asuragen, Inc.'s microRNA Expression Profiling Service Offers Sanger miRBase 8.0 Plus New Proprietary Content; Enhanced Service Offering Will Expand The Number Of microRNAs That Can Be Globally Analyzed For Differential Gene Expression
8/16/2006
-
Asuragen, Inc. Secures MicroRNA Licensing Agreement With Rockefeller University
7/25/2006
-
Newly Launched Asuragen, Inc. Closes Series A Funding Of $49 Million
6/1/2006
-
Digene Corporation Announces Exclusive Marketing And Distribution Agreement With Asuragen, Inc. For Signature Cystic Fibrosis Screening Products
4/19/2006
-
Ingenuity Systems And Asuragen, Inc. Enter Partnership
4/11/2006
-
Ambion, Inc.'s Former CEO And Founder Launches Asuragen, Inc.
3/14/2006
-
New Biotechnology Company Forms And Announces Plan; Asuragen, Inc. Targets Early Diagnosis And Treatment Outcome For Cancer Patients With Key Molecular Diagnostics Research
1/6/2006